These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10672264)

  • 1. Discordance between traditional pathologic and energy metabolic changes in very early Alzheimer's disease. Pathophysiological implications.
    Minoshima S; Cross DJ; Foster NL; Henry TR; Kuhl DE
    Ann N Y Acad Sci; 1999; 893():350-2. PubMed ID: 10672264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease.
    Meguro K; Blaizot X; Kondoh Y; Le Mestric C; Baron JC; Chavoix C
    Brain; 1999 Aug; 122 ( Pt 8)():1519-31. PubMed ID: 10430835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous nonmonotonic changes in functional connectivity and white matter integrity in a rat model of sporadic Alzheimer's disease.
    Tristão Pereira C; Diao Y; Yin T; da Silva AR; Lanz B; Pierzchala K; Poitry-Yamate C; Jelescu IO
    Neuroimage; 2021 Jan; 225():117498. PubMed ID: 33164858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
    Alavi A; Newberg AB; Souder E; Berlin JA
    J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
    Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping histology to metabolism: coregistration of stained whole-brain sections to premortem PET in Alzheimer's disease.
    Mega MS; Chen SS; Thompson PM; Woods RP; Karaca TJ; Tiwari A; Vinters HV; Small GW; Toga AW
    Neuroimage; 1997 Feb; 5(2):147-53. PubMed ID: 9345544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metabolism in the cerebellum and visual cortex correlates with neuropsychological testing in patients with Alzheimer's disease.
    Newberg A; Cotter A; Udeshi M; Brinkman F; Glosser G; Alavi A; Clark C
    Nucl Med Commun; 2003 Jul; 24(7):785-90. PubMed ID: 12813197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of brain glucose metabolism ameliorating cognitive impairment in APP/PS1 transgenic mice by electroacupuncture.
    Liu W; Zhuo P; Li L; Jin H; Lin B; Zhang Y; Liang S; Wu J; Huang J; Wang Z; Lin R; Chen L; Tao J
    Free Radic Biol Med; 2017 Nov; 112():174-190. PubMed ID: 28756309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease.
    Hatanpää K; Brady DR; Stoll J; Rapoport SI; Chandrasekaran K
    Ann Neurol; 1996 Sep; 40(3):411-20. PubMed ID: 8797530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
    Mosconi L
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
    Fukuyama H; Ogawa M; Yamauchi H; Yamaguchi S; Kimura J; Yonekura Y; Konishi J
    J Nucl Med; 1994 Jan; 35(1):1-6. PubMed ID: 8271029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
    VanItallie TB
    Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
    Heiss WD; Szelies B; Kessler J; Herholz K
    Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease.
    Samuraki M; Matsunari I; Yoshita M; Shima K; Noguchi-Shinohara M; Hamaguchi T; Ono K; Yamada M
    J Alzheimers Dis; 2015; 48(2):517-28. PubMed ID: 26402015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical hypometabolism and crossed cerebellar diaschisis suggest subcortically induced disconnection in CADASIL: an 18F-FDG PET study.
    Tatsch K; Koch W; Linke R; Poepperl G; Peters N; Holtmannspoetter M; Dichgans M
    J Nucl Med; 2003 Jun; 44(6):862-9. PubMed ID: 12791811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.